Back to Awarded Treatment Trials


Awarded Trial: 13T-007

Grant ID

13T-007

Illness

schizophrenia

Primary Drug/Intervention

I-tetrahydropalmatine (I-THP)

Primary Dosage

60 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Kelly

Sample Size

60

Duration of Study Period for Each Subject

49 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Deanna Kelly

Degree

N/A

Center

University of Maryland School of Medicine

Institution

Maryland Psychiatric Research Center

Address

Spring Grove Hospital Center

City or Town

Catonsville

State or Province

MD

Zip or Postal Code

21228

Country

USA

Email Address

dkelly@mprc.umaryland.edu